Delivery Order SPE2DB22D6029-SPE2DB25FLVZP
Award Date 9/16/25
Potential Completion Date 9/17/25
Potential Value $1.5K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 18, 2025, for the supply of Doxycycline 25 mg/5 mL suspension in 60 mL quantities, with a ceiling value of $3,238.08. This competitively awarded, non-set-aside delivery order utilizes firm fixed pricing and is scheduled for completion by June 20, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Doxycycline 25 mg/5 mL suspension in 60 mL quantities, with a firm fixed price ceiling value of $2,730.00. This competitive award, which is not set-aside, represents a child delivery order under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.999 billion through December 2026. The...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Doxycycline 25 mg/5 mL suspension in a 60 mL quantity, with a ceiling value of $1,017.72. This contract is structured as a firm fixed-price delivery order with an ultimate completion date of September 4, 2025. The award utilized no set-aside designation, indicating competitive procurement. AmerisourceBergen Drug Corp will perform from its corporate office location in...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,830.34 to AmerisourceBergen Drug Corp for the supply of Doxycycline 100 mg vials. The contract, issued on June 18, 2025, with an ultimate completion date of June 20, 2025, represents a firm fixed-price delivery order with no set-aside designation. Performance will be executed from the vendor's location in Conshohocken, Pennsylvania. This award is a child contract issued under AmerisourceBergen Drug Corp's existing...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Doxycycline Hyclate, an antibiotic medication. This firm fixed-price delivery order, valued at $4,243.50, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which is valued at $999.999 billion and extends through December 2026. The delivery order carries no...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, received a delivery order award from the Defense Logistics Agency valued at $1,994.11 for the supply of Doxycycline 25 mg/5 ml suspension in 60 ml quantities. This award was issued on September 12, 2025, with an ultimate completion date of September 15, 2025, under a firm fixed price delivery order with no set-aside designation. The contract represents a competitive award within the pharmaceutical procurement landscape...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on April 24, 2025, for the supply of Doxycycline Hyclate 20 mg tablets (90-count packaging) with a ceiling value of $1,579.94. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.99 million through December 2026. The contract carries an ultimate completion date...
- The Defense Logistics Agency awarded a delivery order valued at $2,902.88 to AmerisourceBergen Drug Corp for the supply of Doxycycline 25 mg/5 ml Suspension in 60 ml quantities. This competitive award, which was not set-aside, was issued on August 6, 2025, with an ultimate completion date of August 7, 2025, and carries firm fixed price terms. The place of performance is the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a routine...
- The Defense Logistics Agency awarded a $20,468.22 delivery order to AmerisourceBergen Drug Corp for 60-tablet units of Doxycycline 50 mg on July 29, 2025, with an ultimate completion date of July 30, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The place of performance is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Doxycycline IR-DR 40 mg capsules (30-count) with a contract value of $3,077.22. This is a firm fixed-price delivery order with an ultimate completion date of August 27, 2025, and no set-aside designation was utilized. The order will be performed in Conshohocken, Pennsylvania, the location of AmerisourceBergen's corporate headquarters. This delivery order represents a child...